Sidekhmenova A V, Aliev O I, Domnina N S, Vlasov P S, Popova E V, Plotnikov M B
Laboratory of Pharmacology of Blood Circulation, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Institute of Chemistry, St. Petersburg State University, St. Petersburg, Russia.
Bull Exp Biol Med. 2022 Feb;172(4):504-506. doi: 10.1007/s10517-022-05423-4. Epub 2022 Feb 17.
We developed a model of blood hyperviscosity avoiding extreme impact on the blood. The model shows reproducibility in rat blood under common storage conditions (4±1°C; stabilization with citrate-phosphate-glucose additive solution). Storage of rat blood under these condition leads to impairment of its rheological properties, which manifested in an increase in blood viscosity in a wide range of shear rates (3-300 sec). An increase in blood viscosity appeared the first day of storage and reached a maximum on the third day. During further 11-day storage, the blood viscosity did not change significantly. A hybrid macromolecular compound O-(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl)-(1→6)-α-D-glucan improved the hemorheological properties during storage. The most pronounced effect was observed on the third day of storage and manifested in a decrease in blood viscosity in the range of shear rates of 50-300 sec. Thus, storage of rat blood with citrate-phosphate-glucose additive solution for 3 days at 4±1°C reproduces the phenomenon of blood hyperviscosity; this model can be used to screen agents with hemorheological activity.
我们开发了一种血液高粘滞度模型,避免对血液造成极端影响。该模型在大鼠血液于常见储存条件下(4±1°C;用枸橼酸盐 - 磷酸盐 - 葡萄糖添加剂溶液稳定)具有可重复性。在这些条件下储存大鼠血液会导致其流变学特性受损,这表现为在广泛的剪切速率范围(3 - 300秒)内血液粘度增加。血液粘度在储存第一天开始升高,并在第三天达到最大值。在接下来的11天储存期间,血液粘度没有显著变化。一种杂化大分子化合物O-(3-(3,5 - 二叔丁基 - 4 - 羟基苯基)丙酰基)-(1→6)-α-D-葡聚糖在储存期间改善了血液流变学特性。在储存第三天观察到最明显的效果,表现为在50 - 300秒的剪切速率范围内血液粘度降低。因此,大鼠血液与枸橼酸盐 - 磷酸盐 - 葡萄糖添加剂溶液在4±1°C下储存3天可重现血液高粘滞度现象;该模型可用于筛选具有血液流变学活性的药物。